Velcade, Thalidomide and Dexamethasone (VTD) Regimen Followed by High-Dose Chemotherapy Plus Autologous Stem Cell Transplant (HDT-ASCT) as Front-Line treatment in Newly Diagnosed Multiple Myeloma (MM) Patients: Preliminary Results of An ongoing Open Label Study

Autor: Di Renzo, Nicola, Pennese, Elsa *, Forese, Pasquale *, Reddiconto, Giovanni *, Matera, Rosella *, Vergine, Carolina *, Falcone, Antonia *, Cascavilla, Nicola *
Zdroj: In Blood 16 November 2008 112(11):5203-5203
Databáze: ScienceDirect